Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenugreek Fibre for Gut Microbiome
NCT06006416Phase 3Withdrawn
- Sponsor
- RDC Clinical
- Start
- Dec 2024
- Primary completion
- May 2025
01
Overview
Phase 3, open-label, single-arm trial, sponsored by RDC Clinical. Primary endpoint: Change in metagenomic profile of the gut microbiome at Week 16. Planned start Dec 2024; status: withdrawn.
Beyond the preview
Go deeper on NCT06006416.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06006416.